论文部分内容阅读
三年多来我们应用康力龙、一叶萩碱、左旋咪唑治疗慢性再生障碍贫血(以下简称慢性再障)12例,经过随访其疗效尚满意,现总结如下。资料与方法一、一般资料:本组12例,男性8例,女性4例;年龄最小16岁,最大57岁,平均26.5岁。均未查出诱发病因,故属于原发性慢性再障,10例为初治病人,2例为复发复治的病人。乙肝表面抗原(HB_sAg)阳性者5例。
In the past three years, we applied KangLongLong, leucovorin, and levamisole in treating 12 cases of chronic aplastic anemia (hereinafter referred to as chronic aplastic anemia). After follow-up, the curative effect is still satisfactory, and are summarized as follows. Materials and Methods First, the general information: The group of 12 patients, 8 males and 4 females; the youngest 16 years old, maximum 57 years old, average 26.5 years old. Have not found the etiology, it belongs to the primary chronic aplastic anemia, 10 cases of newly diagnosed patients, 2 cases of recurrent re-treatment of patients. Hepatitis B surface antigen (HB_sAg) positive in 5 cases.